Criminal Investigation for Excess Deaths Due to Remdesivir
The U.S. Food and Drug Administration authorized the experimental antiviral drug remdesivir, brand name Veklury, for emergency use against COVID-19 in May 2020.1 By October 2020, it had received full approval.2 It remains a primary treatment for COVID-19 in hospitals, despite research showing it lacks effectiveness3 and can cause high rates of organ failure.4 On… Read More »